Open AccessRandomized controlled study on preoperative chemoradiotherapy followed by surgery versus surgery alone for esophageal squamous cell cancer in a single institution
Author(s) -
Natsugoe S.,
Okumura H.,
Matsumoto M.,
Uchikado Y.,
Setoyama T.,
Yokomakura N.,
Ishigami S.,
Owaki T.,
Aikou T.
Publication year - 2006
Publication title -
diseases of the esophagus
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.115
H-Index - 63
eISSN - 1442-2050
pISSN - 1120-8694
DOI - 10.1111/j.1442-2050.2006.00615.x
Subject(s) - medicine , randomized controlled trial , esophageal cancer , surgery , chemoradiotherapy , radiation therapy , esophagectomy , fluorouracil , chemotherapy , cancer
SUMMARY. The purpose of the present study was to compare the clinical results between preoperative chemoradiotherapy followed by surgery (CRT group) and surgery alone (Surgery group) by a randomized controlled study. Twenty‐two patients were assigned to the CRT group and 23 to the Surgery group. A total radiation dose of 40 Gy was applied and in the same period, intravenous chemotherapy was performed using cisplatin (7 mg over 2 h) and 5‐fluorouracil (5‐FU; 350 mg over 24 h). Surgical treatment was performed in 20 patients in the CRT group except for two patients with bone metastasis after CRT. According to histological effects of primary tumors, the number of patient with Grades 1, 2 and 3 was 11, 7 and 3, respectively. Frequency of lymphatic and venous invasion was significantly lower in the CRT group than in the Surgery group. The 5‐year survival rate was 57% in the CRT group and 41% in the Surgery group ( P = 0.58). According to the histological effect in the CRT group, 5‐year survival was 30% for Grade 1, 83% for Grade 2 and 100% for Grade 3 ( P = 0.0069). This randomized trial did not demonstrate a statistically significant survival difference between the CRT group and the Surgery group.